Technology & Software Global On demand · 24-48h

Global AI Fetal Ultrasound View Detection Software Market Strategic Research Report

Name: Global AI Fetal Ultrasound View Detection Software Market Strategic Research Report
Brand: Market Research Reports, Inc.
Price: 3500 USD
Availability: PreOrder

Global AI Fetal Ultrasound View Detection Software Market St…

$3,500 USD

Strategic Research Report

Global AI Fetal Ultrasound View Detection Software Market

$3192025

16.7%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: On-Premise / Cart-Based, Cloud-Based SaaS, Edge / Handheld Device

By Application: Hospitals (Radiology/OB-GYN Departments), Outpatient Ultrasound Clinics, Maternal-Fetal Medicine Practices, Point-of-Care / Remote Settings

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Sonio (Samsung Medison), BrightHeart, Fraiya, Diagnoly, DeepEcho Inc., GE Healthcare, Siemens Healthineers, Butterfly Network, Canon Medical Systems, Fujifilm Healthcare, Clarius Mobile Health, EchoNous, Exo AI, Esaote

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2025 · forecast to 2032

Length: 102 pages

Market size 2025

$319

Million USD

Forecast CAGR

16.7%

2025-2032

Forecast 2032

$940.3

Projected

영역들

Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global AI Fetal Ultrasound View Detection Software market size is predicted to grow from US$ 319 million in 2025 to US$ 933 million in 2032; it is expected to grow at a CAGR of 16.7% from 2026 to 2032.

AI fetal ultrasound view detection software refers to artificial intelligence-powered medical software devices that automatically identify, classify, and verify fetal anatomical views during routine prenatal ultrasound examinations. Unlike traditional manual image review, these AI systems leverage deep learning algorithms to analyze real-time ultrasound video streams or static images, detecting standard fetal views (e.g., four-chamber heart view, profile view, brain views), assessing image quality, and flagging missing or suboptimal views. Key functionalities include automated view recognition, real-time quality feedback, anomaly detection assistance, and exam completeness verification. From a value chain perspective, upstream includes AI chip and GPU suppliers, cloud infrastructure providers, and medical imaging data sources; midstream involves algorithm development, software engineering, regulatory certification (FDA 510(k), CE-MDR), and integration with ultrasound hardware; downstream demand spans hospitals, ultrasound clinics, maternal-fetal medicine practices, and point-of-care settings. In 2025, the market is characterized by rapid regulatory clearances and increasing clinical adoption, with gross margins generally ranging from 60% to 85%, driven by R&D costs, regulatory compliance expenses, and software integration complexity.

Global key AI Fetal Ultrasound View Detection Software players cover Sonio (Samsung Medison), BrightHeart, Fraiya, Diagnoly, DeepEcho Inc., etc.

This report presents a comprehensive overview of the global AI Fetal Ultrasound View Detection Software market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

On-Premise / Cart-Based
Cloud-Based SaaS
Edge / Handheld Device

Segment by AI Technology Type

Deep Learning (CNN) Based
Video Stream Analysis
Image Classification
Object Detection / Segmentation

Segment by Workflow Integration Point

Real-Time during Image Acquisition
Post-Exam Review / Reporting
Second Review / Quality Assurance

Segment by Application

Hospitals (Radiology/OB-GYN Departments)
Outpatient Ultrasound Clinics
Maternal-Fetal Medicine Practices
Point-of-Care / Remote Settings

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global AI Fetal Ultrasound View Detection Software market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Hospitals (Radiology/OB-GYN Departments), Outpatient Ultrasound Clinics, Maternal-Fetal Medicine Practices evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global AI Fetal Ultrasound View Detection Software Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports

Market size CAGR 16.7%

Regional growth momentum

Market share by segment

Key metrics

Base value

$319

2025

Forecast

$940.3

2032

CAGR

16.7%

2025–2032

영역들

global

Key companies

Sonio (Samsung Medison)BrightHeartFraiyaDiagnolyDeepEcho Inc.GE HealthcareSiemens HealthineersButterfly Network

Segments covered in this report

By Type

On-Premise / Cart-BasedCloud-Based SaaSEdge / Handheld Device

By Application

Hospitals (Radiology/OB-GYN Departments)Outpatient Ultrasound ClinicsMaternal-Fetal Medicine PracticesPoint-of-Care / Remote Settings

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 On-Premise / Cart-Based
3.1.3 Cloud-Based SaaS
3.1.4 Edge / Handheld Device
3.1.5 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Hospitals (Radiology/OB-GYN Departments)
4.1.3 Outpatient Ultrasound Clinics
4.1.4 Maternal-Fetal Medicine Practices
4.1.5 Point-of-Care / Remote Settings
4.1.6 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 Sonio (Samsung Medison)
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 BrightHeart
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 Fraiya
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 Diagnoly
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 DeepEcho Inc.
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 GE Healthcare
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 Siemens Healthineers
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 Butterfly Network
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 Canon Medical Systems
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 Fujifilm Healthcare
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Clarius Mobile Health
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 EchoNous
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 Exo AI
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 Esaote
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global AI Fetal Ultrasound View Detection Software market?

The global AI Fetal Ultrasound View Detection Software market is estimated at US$ 319 million in 2025 (base year) and is projected to reach US$ 933 million by 2032.

How fast is the AI Fetal Ultrasound View Detection Software market expected to grow?

The market is expected to grow at a CAGR of 16.7% from 2026 to 2032, expanding from US$ 319 million in 2025 to US$ 933 million in 2032, roughly 2.9 times its base-year value.

What does the AI Fetal Ultrasound View Detection Software market cover?

How is the AI Fetal Ultrasound View Detection Software market segmented by type?

By type, the market is segmented into On-Premise / Cart-Based, Cloud-Based SaaS and Edge / Handheld Device.

What are the key applications of AI Fetal Ultrasound View Detection Software?

Key applications covered include Hospitals (Radiology/OB-GYN Departments), Outpatient Ultrasound Clinics, Maternal-Fetal Medicine Practices and Point-of-Care / Remote Settings.

Which companies are profiled in the AI Fetal Ultrasound View Detection Software market report?

Key players profiled include Sonio (Samsung Medison), BrightHeart, Fraiya, Diagnoly, DeepEcho Inc., GE Healthcare, Siemens Healthineers and Butterfly Network, among 14 companies covered in total.

What geographies does the AI Fetal Ultrasound View Detection Software market analysis include?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

What are the key demand drivers for AI Fetal Ultrasound View Detection Software?

In 2025, the market is characterized by rapid regulatory clearances and increasing clinical adoption, with gross margins generally ranging from 60% to 85%, driven by R&D costs, regulatory compliance expenses, and software integration complexity.

Who should buy the AI Fetal Ultrasound View Detection Software market report?

The report is intended for manufacturers and solution providers, distributors and end users in Hospitals (Radiology/OB-GYN Departments), Outpatient Ultrasound Clinics and Maternal-Fetal Medicine Practices, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the AI Fetal Ultrasound View Detection Software market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.